Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy

CompletedOBSERVATIONAL
Enrollment

1,032

Participants

Timeline

Start Date

April 26, 2018

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
Severe Asthma
Trial Locations (12)

1135

Research Site, Budapest

2380

Research Site, Slovenj Gradec

5800

Research Site, Pleven

7100

Research Site, Sardinia

12242

Research Site, Athens

23858

Research Site, Reinfeld

29004

Research Site, Málaga

59242

Research Site, Cappelle-en-Pévèle

73506

Research Site, Havířov

98400

Research Site, Wieruszów

600114

Research Site, Bacau

9745 DH

Research Site, Groningen

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY